GulbuUzelMD

Allergy & Immunology • Springfield, VA

Clinical & Laboratory Immunology

Physician

Join to view full profile

Dr. Uzel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Uzel's full profile

Already have an account?

Office
8136 Old Keene Mill Rd
Ste A309
Springfield, VA 22152
Phone+1 800-287-2829

Fax+1 703-726-2579

Education & Training

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1997 - 1999
Sinai Hospital of BaltimoreResidency, Pediatrics, 1994 - 1997
Ankara University FOMClass of 1991

Certifications & Licensure

MD State Medical License 2002 - 2025
VA State Medical License 2007 - 2022
IL State Medical License 2002 - 2008

Clinical Trials

Genetic Analysis of Immune Disorders Start of enrollment: 1995 Jun 06
Recruiting
Antibody Production in Immune Disorders Start of enrollment: 2002 Jun 13
Terminated
Phase 4
Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency Start of enrollment: 2023 Nov 30
Withdrawn
Phase 1, Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

452 citations
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Amy P. Hsu, Elizabeth P. Sampaio, Javed Khan, Katherine R. Calvo, Jacob E. Lemieux
Blood. 2011-09-08
67 citations
Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets
Cindy S. Ma, Natalie Wong, Geetha Rao, Akira Nguyen, Danielle T. Avery
The Journal of Experimental Medicine. 2016-07-25
156 citations
Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies
Cindy S. Ma, Natalie Wong, Geetha Rao, Danielle T. Avery, James Torpy
The Journal of Allergy and Clinical Immunology. 2015-10-01

Other

Mendelian susceptibility to mycobacterial diseases (MSMD)
Uzel G
http://www.uptodate.com/contents/mendelian-susceptibility-to-mycobacterial-diseases-msmd
UpToDate, Wolters Kluwer Health - 2012-09-19

Press Mentions

Pharming Group Announces Development Plans for Leniolisib for Additional Primary Immunodeficiencies (PIDs)December 17th, 2023